6 November 2025 -  Hikma Pharmaceuticals today announced the launch of Starjemza (ustekinumab-hmny) Injection, a biosimilar referencing Stelara (ustekinumab) Injection. 

According to IQVIA, US sales of ustekinumab were approximately $17.1 billion for the 12 months ending December 2024.

Read Hikma Pharmaceuticals press release